Stuart B. Levy, M.D. - Publications

Affiliations: 
Molecular Biology and Microbiology Tufts University, Boston 
Area:
Antimicrobial resistance
Website:
http://www.tuftsmedicalcenter.org/apps/TuftsFindAPhysician/PhysicianDetail.aspx?OID=1921

223 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Molina-Quiroz RC, Silva-Valenzuela C, Brewster J, Castro-Nallar E, Levy SB, Camilli A. Cyclic AMP Regulates Bacterial Persistence through Repression of the Oxidative Stress Response and SOS-Dependent DNA Repair in Uropathogenic Escherichia coli. Mbio. 9. PMID 29317513 DOI: 10.1128/Mbio.02144-17  0.375
2017 Duval V, Foster K, Brewster J, Levy SB. A Novel Regulatory Cascade Involving BluR, YcgZ, and Lon Controls the Expression of Escherichia coli OmpF Porin. Frontiers in Microbiology. 8: 1148. PMID 28713335 DOI: 10.3389/Fmicb.2017.01148  0.318
2016 McNamara PJ, Levy SB. Triclosan: An Instructive Tale. Antimicrobial Agents and Chemotherapy. PMID 27736758 DOI: 10.1128/Aac.02105-16  0.418
2016 Molina-Quiroz RC, Lazinski DW, Camilli A, Levy SB. Transposon-sequencing analysis unveils novel genes involved in the generation of persister cells in uropathogenic Escherichia coli. Antimicrobial Agents and Chemotherapy. PMID 27550350 DOI: 10.1128/Aac.01617-16  0.341
2015 Honeyman L, Ismail M, Nelson ML, Bhatia B, Bowser TE, Chen J, Mechiche R, Ohemeng K, Verma AK, Cannon EP, Macone A, Tanaka SK, Levy S. Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline. Antimicrobial Agents and Chemotherapy. 59: 7044-53. PMID 26349824 DOI: 10.1128/Aac.01536-15  0.483
2015 Dalhoff AA, Levy SB. Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern. International Journal of Antimicrobial Agents. 45: 564-7. PMID 25862309 DOI: 10.1016/J.Ijantimicag.2015.02.011  0.374
2014 Macone AB, Caruso BK, Leahy RG, Donatelli J, Weir S, Draper MP, Tanaka SK, Levy SB. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline. Antimicrobial Agents and Chemotherapy. 58: 1127-35. PMID 24295985 DOI: 10.1128/Aac.01242-13  0.435
2014 Ruiz C, Levy SB. Regulation of acrAB expression by cellular metabolites in Escherichia coli. The Journal of Antimicrobial Chemotherapy. 69: 390-9. PMID 24043404 DOI: 10.1093/Jac/Dkt352  0.432
2014 Draper MP, Weir S, Macone A, Donatelli J, Trieber CA, Tanaka SK, Levy SB. Mechanism of action of the novel aminomethylcycline antibiotic omadacycline. Antimicrobial Agents and Chemotherapy. 58: 1279-83. PMID 24041885 DOI: 10.1128/Aac.01066-13  0.464
2013 McMurry LM, Levy SB. Amino acid residues involved in inactivation of the Escherichia coli multidrug resistance repressor MarR by salicylate, 2,4-dinitrophenol, and plumbagin. Fems Microbiology Letters. 349: 16-24. PMID 24111786 DOI: 10.1111/1574-6968.12291  0.351
2013 Warner DM, Duval V, Levy SB. The contribution of PmrAB to the virulence of a clinical isolate of Escherichia coli. Virulence. 4: 634-7. PMID 23921442 DOI: 10.4161/Viru.25931  0.372
2013 Vinué L, McMurry LM, Levy SB. The 216-bp marB gene of the marRAB operon in Escherichia coli encodes a periplasmic protein which reduces the transcription rate of marA. Fems Microbiology Letters. 345: 49-55. PMID 23710538 DOI: 10.1111/1574-6968.12182  0.378
2013 Duval V, McMurry LM, Foster K, Head JF, Levy SB. Mutational analysis of the multiple-antibiotic resistance regulator MarR reveals a ligand binding pocket at the interface between the dimerization and DNA binding domains. Journal of Bacteriology. 195: 3341-51. PMID 23687277 DOI: 10.1128/Jb.02224-12  0.315
2013 Levy SB, Marshall BM. Honeybees and tetracycline resistance. Mbio. 4: e00045-13. PMID 23404397 DOI: 10.1128/Mbio.00045-13  0.482
2013 Warner DM, Yang Q, Duval V, Chen M, Xu Y, Levy SB. Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China. Antimicrobial Agents and Chemotherapy. 57: 1935-7. PMID 23318808 DOI: 10.1128/Aac.02445-12  0.474
2012 Marshall BM, Robleto E, Dumont T, Levy SB. The frequency of antibiotic-resistant bacteria in homes differing in their use of surface antibacterial agents. Current Microbiology. 65: 407-15. PMID 22752336 DOI: 10.1007/S00284-012-0172-X  0.385
2012 Mastropaolo MD, Silby MW, Nicoll JS, Levy SB. Novel genes involved in Pseudomonas fluorescens Pf0-1 motility and biofilm formation. Applied and Environmental Microbiology. 78: 4318-29. PMID 22492452 DOI: 10.1128/Aem.07201-11  0.322
2012 Warner DM, Levy SB. SoxS increases the expression of the zinc uptake system ZnuACB in an Escherichia coli murine pyelonephritis model. Journal of Bacteriology. 194: 1177-85. PMID 22210763 DOI: 10.1128/Jb.05451-11  0.327
2012 Lister IM, Raftery C, Mecsas J, Levy SB. Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence. Antimicrobial Agents and Chemotherapy. 56: 1120-3. PMID 22083483 DOI: 10.1128/Aac.05338-11  0.459
2012 Lichtenstein SJ, De Leon L, Heller W, Marshall B, Cupp G, Foster K, McLean C, Levy S, Stroman DW. Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat. Journal of Pediatric Ophthalmology and Strabismus. 49: 88-97. PMID 22074357 DOI: 10.3928/01913913-20111101-02  0.352
2011 Nelson ML, Levy SB. The history of the tetracyclines. Annals of the New York Academy of Sciences. 1241: 17-32. PMID 22191524 DOI: 10.1111/J.1749-6632.2011.06354.X  0.361
2011 Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, et al. Tackling antibiotic resistance. Nature Reviews. Microbiology. 9: 894-6. PMID 22048738 DOI: 10.1038/Nrmicro2693  0.458
2011 Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clinical Microbiology Reviews. 24: 718-33. PMID 21976606 DOI: 10.1128/Cmr.00002-11  0.424
2011 McMurry LM, Levy SB. The periplasmic protein MppA is not involved in regulation of marA in Escherichia coli. Antimicrobial Agents and Chemotherapy. 55: 4939. PMID 21788455 DOI: 10.1128/Aac.05030-11  0.327
2011 Livermore DM, Blaser M, Carrs O, Cassell G, Fishman N, Guidos R, Levy S, Powers J, Norrby R, Tillotson G, Davies R, Projan S, Dawson M, Monnet D, Keogh-Brown M, et al. Discovery research: the scientific challenge of finding new antibiotics Journal of Antimicrobial Chemotherapy. 66: 1941-1944. PMID 21700626 DOI: 10.1093/Jac/Dkr262  0.368
2011 White AR, Blaser M, Carrs O, Cassell G, Fishman N, Guidos R, Levy S, Powers J, Norrby R, Tillotson G, Davies R, Projan S, Dawson M, Monnet D, Keogh-brown M, et al. Effective antibacterials: At what cost? The economics of antibacterial resistance and its control Journal of Antimicrobial Chemotherapy. 66: 1948-1953. PMID 21700625 DOI: 10.1093/Jac/Dkr260  0.311
2011 Silby MW, Winstanley C, Godfrey SA, Levy SB, Jackson RW. Pseudomonas genomes: diverse and adaptable. Fems Microbiology Reviews. 35: 652-80. PMID 21361996 DOI: 10.1111/J.1574-6976.2011.00269.X  0.305
2011 Garbeva P, Silby MW, Raaijmakers JM, Levy SB, Boer Wd. Transcriptional and antagonistic responses of Pseudomonas fluorescens Pf0-1 to phylogenetically different bacterial competitors. The Isme Journal. 5: 973-85. PMID 21228890 DOI: 10.1038/Ismej.2010.196  0.356
2011 Ruiz C, Levy SB. Use of functional interactions with MarA to discover chromosomal genes affecting antibiotic susceptibility in Escherichia coli. International Journal of Antimicrobial Agents. 37: 177-8. PMID 21185159 DOI: 10.1016/J.Ijantimicag.2010.10.007  0.507
2011 Domain F, Bina XR, Levy SB. Transketolase A, an enzyme in central metabolism, derepresses the marRAB multiple antibiotic resistance operon of Escherichia coli by interaction with MarR: Corrigendum Molecular Microbiology. 80: 853-853. DOI: 10.1111/J.1365-2958.2011.07642.X  0.406
2010 Garrity-Ryan LK, Kim OK, Balada-Llasat JM, Bartlett VJ, Verma AK, Fisher ML, Castillo C, Songsungthong W, Tanaka SK, Levy SB, Mecsas J, Alekshun MN. Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model. Infection and Immunity. 78: 4683-90. PMID 20823209 DOI: 10.1128/Iai.01305-09  0.311
2010 McMurry LM, Levy SB. Evidence that regulatory protein MarA of Escherichia coli represses rob by steric hindrance. Journal of Bacteriology. 192: 3977-82. PMID 20453091 DOI: 10.1128/Jb.00103-10  0.323
2010 Grier MC, Garrity-Ryan LK, Bartlett VJ, Klausner KA, Donovan PJ, Dudley C, Alekshun MN, Tanaka SK, Draper MP, Levy SB, Kim OK. N-Hydroxybenzimidazole inhibitors of ExsA MAR transcription factor in Pseudomonas aeruginosa: In vitro anti-virulence activity and metabolic stability. Bioorganic & Medicinal Chemistry Letters. 20: 3380-3. PMID 20434913 DOI: 10.1016/J.Bmcl.2010.04.014  0.306
2010 Ruiz C, Levy SB. Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy. 54: 2125-34. PMID 20211899 DOI: 10.1128/Aac.01420-09  0.466
2010 Domain F, Levy SB. GyrA interacts with MarR to reduce repression of the marRAB operon in Escherichia coli. Journal of Bacteriology. 192: 942-8. PMID 19933356 DOI: 10.1128/Jb.01259-09  0.443
2010 Warner DM, Levy SB. Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon. Microbiology (Reading, England). 156: 570-8. PMID 19926649 DOI: 10.1099/Mic.0.033415-0  0.417
2010 Lister IM, Mecsas J, Levy SB. Effect of MarA-like proteins on antibiotic resistance and virulence in Yersinia pestis. Infection and Immunity. 78: 364-71. PMID 19841071 DOI: 10.1128/Iai.00904-09  0.454
2010 Lichtenstein SJ, Marshall B, Cupp G, Cockrum P, Levy S, Stroman D. The effect of moxifloxacin treatment on fluoroquinolone susceptibility of the major pathogenic species in bacterial conjunctivitis Journal of Aapos. 14. DOI: 10.1016/J.Jaapos.2009.12.022  0.318
2009 Roberts RR, Hota B, Ahmad I, Scott RD, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1175-84. PMID 19739972 DOI: 10.1086/605630  0.395
2009 Duval V, Nicoloff H, Levy SB. Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli. Antimicrobial Agents and Chemotherapy. 53: 4944-8. PMID 19721064 DOI: 10.1128/Aac.00787-09  0.431
2009 Marshall BM, Ochieng DJ, Levy SB. Commensals: Underappreciated reservoir of antibiotic resistance Microbe. 4: 231-238. DOI: 10.1128/Microbe.4.231.1  0.478
2008 Carson RT, Larson E, Levy SB, Marshall BM, Aiello AE. Use of antibacterial consumer products containing quaternary ammonium compounds and drug resistance in the community. The Journal of Antimicrobial Chemotherapy. 62: 1160-2. PMID 18694904 DOI: 10.1093/Jac/Dkn332  0.468
2008 Levy SB. Genome size and antibiotic resistance. Antimicrobial Agents and Chemotherapy. 52: 2696. PMID 18577753 DOI: 10.1128/Aac.01024-07  0.482
2008 Silby MW, Levy SB. Overlapping protein-encoding genes in Pseudomonas fluorescens Pf0-1. Plos Genetics. 4: e1000094. PMID 18551168 DOI: 10.1371/Journal.Pgen.1000094  0.315
2008 Ruiz C, McMurry LM, Levy SB. Role of the multidrug resistance regulator MarA in global regulation of the hdeAB acid resistance operon in Escherichia coli. Journal of Bacteriology. 190: 1290-7. PMID 18083817 DOI: 10.1128/Jb.01729-07  0.377
2008 McDermott PF, McMurry LM, Podglajen I, Dzink-Fox JL, Schneiders T, Draper MP, Levy SB. The marC gene of Escherichia coli is not involved in multiple antibiotic resistance. Antimicrobial Agents and Chemotherapy. 52: 382-3. PMID 17954692 DOI: 10.1128/Aac.00930-07  0.463
2007 Domain F, Bina XR, Levy SB. Transketolase A, an enzyme in central metabolism, derepresses the marRAB multiple antibiotic resistance operon of Escherichia coli by interaction with MarR. Molecular Microbiology. 66: 383-94. PMID 17850260 DOI: 10.1111/J.1365-2958.2007.05928.X  0.431
2007 Bowser TE, Bartlett VJ, Grier MC, Verma AK, Warchol T, Levy SB, Alekshun MN. Novel anti-infection agents: small-molecule inhibitors of bacterial transcription factors. Bioorganic & Medicinal Chemistry Letters. 17: 5652-5. PMID 17766109 DOI: 10.1016/J.Bmcl.2007.07.072  0.351
2007 Aiello AE, Larson EL, Levy SB. Consumer antibacterial soaps: effective or just risky? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: S137-47. PMID 17683018 DOI: 10.1086/519255  0.396
2007 Sapunaric FM, Levy SB. Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate. Antimicrobial Agents and Chemotherapy. 51: 3036-7. PMID 17517833 DOI: 10.1128/Aac.00357-07  0.369
2007 Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell. 128: 1037-50. PMID 17382878 DOI: 10.1016/J.Cell.2007.03.004  0.475
2007 Nicoloff H, Perreten V, Levy SB. Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications. Antimicrobial Agents and Chemotherapy. 51: 1293-303. PMID 17220404 DOI: 10.1128/Aac.01128-06  0.419
2006 Casaz P, Garrity-Ryan LK, McKenney D, Jackson C, Levy SB, Tanaka SK, Alekshun MN. MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis. Microbiology (Reading, England). 152: 3643-50. PMID 17159217 DOI: 10.1099/Mic.0.2006/000604-0  0.385
2006 Udani RA, Levy SB. MarA-like regulator of multidrug resistance in Yersinia pestis. Antimicrobial Agents and Chemotherapy. 50: 2971-5. PMID 16940090 DOI: 10.1128/Aac.00015-06  0.494
2006 Nicoloff H, Perreten V, McMurry LM, Levy SB. Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB. Journal of Bacteriology. 188: 4413-23. PMID 16740948 DOI: 10.1128/Jb.01502-05  0.484
2006 Levy SB. Mechanisms for resistance in soil. Science (New York, N.Y.). 312: 529. PMID 16645078 DOI: 10.1126/Science.312.5773.529A  0.34
2006 Schneiders T, Levy SB. MarA-mediated transcriptional repression of the rob promoter. The Journal of Biological Chemistry. 281: 10049-55. PMID 16478729 DOI: 10.1074/Jbc.M512097200  0.309
2006 Ades S, Maxfield LF, Gould CJ, Jones GK, Levy SB. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors. International Journal of Oncology. 28: 747-53. PMID 16465381 DOI: 10.3892/Ijo.28.3.747  0.388
2006 Alekshun MN, Levy SB. Commensals upon us. Biochemical Pharmacology. 71: 893-900. PMID 16464437 DOI: 10.1016/J.Bcp.2005.12.040  0.42
2005 Aiello AE, Marshall B, Levy SB, Della-Latta P, Lin SX, Larson E. Antibacterial cleaning products and drug resistance. Emerging Infectious Diseases. 11: 1565-70. PMID 16318697 DOI: 10.3201/Eid1110.041276  0.404
2005 Levy SB, O'Brien TF. Global antimicrobial resistance alerts and implications. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: S219-20. PMID 16032554 DOI: 10.1086/432443  0.455
2005 Sapunaric FM, Levy SB. Substitutions in the interdomain loop of the Tn10 TetA efflux transporter alter tetracycline resistance and substrate specificity. Microbiology (Reading, England). 151: 2315-22. PMID 16000721 DOI: 10.1099/Mic.0.27997-0  0.408
2005 Levy SB, McMurry LM, Roberts MC. Tet protein hybrids. Antimicrobial Agents and Chemotherapy. 49: 3099. PMID 15980411 DOI: 10.1128/Aac.49.7.3099.2005  0.327
2005 Stelling JM, Travers K, Jones RN, Turner PJ, O'Brien TF, Levy SB. Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerging Infectious Diseases. 11: 873-82. PMID 15963282 DOI: 10.3201/Eid1106.041160  0.352
2005 Levy SB. Antibiotic resistance-the problem intensifies. Advanced Drug Delivery Reviews. 57: 1446-50. PMID 15949867 DOI: 10.1016/J.Addr.2005.04.001  0.472
2004 Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nature Medicine. 10: S122-9. PMID 15577930 DOI: 10.1038/Nm1145  0.465
2004 Aiello AE, Marshall B, Levy SB, Della-Latta P, Larson E. Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrobial Agents and Chemotherapy. 48: 2973-9. PMID 15273108 DOI: 10.1128/Aac.48.8.2973-2979.2004  0.34
2004 Schneiders T, Barbosa TM, McMurry LM, Levy SB. The Escherichia coli transcriptional regulator MarA directly represses transcription of purA and hdeA. The Journal of Biological Chemistry. 279: 9037-42. PMID 14701822 DOI: 10.1074/Jbc.M313602200  0.315
2004 Alekshun MN, Levy SB. The Escherichia coli mar locus-antibiotic resistance and more Asm News. 70: 451-456.  0.398
2003 Schneiders T, Amyes SG, Levy SB. Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrobial Agents and Chemotherapy. 47: 2831-7. PMID 12936981 DOI: 10.1128/Aac.47.9.2831-2837.2003  0.454
2003 Sapunaric FM, Levy SB. Second-site suppressor mutations for the serine 202 to phenylalanine substitution within the interdomain loop of the tetracycline efflux protein Tet(C). The Journal of Biological Chemistry. 278: 28588-92. PMID 12766164 DOI: 10.1074/Jbc.M302658200  0.406
2003 Bina X, Perreten V, Levy SB. The periplasmic protein MppA requires an additional mutated locus to repress marA expression in Escherichia coli. Journal of Bacteriology. 185: 1465-9. PMID 12562820 DOI: 10.1128/Jb.185.4.1465-1469.2003  0.392
2003 Robleto EA, López-Hernández I, Silby MW, Levy SB. Genetic analysis of the AdnA regulon in Pseudomonas fluorescens: nonessential role of flagella in adhesion to sand and biofilm formation. Journal of Bacteriology. 185: 453-60. PMID 12511490 DOI: 10.1128/Jb.185.2.453-460.2003  0.355
2002 Levy SB. Active efflux, a common mechanism for biocide and antibiotic resistance. Symposium Series (Society For Applied Microbiology). 65S-71S. PMID 12481830 DOI: 10.1046/J.1365-2672.92.5S1.4.X  0.466
2002 Barbosa TM, Levy SB. Activation of the Escherichia coli nfnB gene by MarA through a highly divergent marbox in a class II promoter. Molecular Microbiology. 45: 191-202. PMID 12100559 DOI: 10.1046/J.1365-2958.2002.03006.X  0.382
2002 Levy SB. Active efflux, a common mechanism for biocide and antibiotic resistance. Journal of Applied Microbiology. 92: 65S-71S. PMID 12000614  0.363
2002 Joshi PP, Levy SB. Carriage of antibiotic-resistant fecal bacteria in Nepal [1] (multiple letters) Journal of Infectious Diseases. 185: 1542. PMID 11992296 DOI: 10.1086/340208  0.375
2002 Levy SB. The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. The Journal of Antimicrobial Chemotherapy. 49: 25-30. PMID 11751763 DOI: 10.1093/Jac/49.1.25  0.477
2001 Walson JL, Marshall B, Pokhrel BM, Kafle KK, Levy SB. Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. The Journal of Infectious Diseases. 184: 1163-9. PMID 11598839 DOI: 10.1086/323647  0.42
2001 Levy SB. Antimicrobial resistance potential. Lancet. 358: 1100-1. PMID 11594326 DOI: 10.1016/S0140-6736(01)06215-8  0.453
2001 Levy SB. Antibiotic resistance: consequences of inaction. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 33: S124-9. PMID 11524708 DOI: 10.1086/321837  0.469
2001 Levy SB. Antibacterial household products: cause for concern. Emerging Infectious Diseases. 7: 512-5. PMID 11485643 DOI: 10.3201/Eid0707.017705  0.39
2001 Alekshun MN, Levy SB, Mealy TR, Seaton BA, Head JF. The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution. Nature Structural Biology. 8: 710-4. PMID 11473263 DOI: 10.1038/90429  0.404
2001 Wang H, Dzink-Fox JL, Chen M, Levy SB. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrobial Agents and Chemotherapy. 45: 1515-21. PMID 11302820 DOI: 10.1128/Aac.45.5.1515-1521.2001  0.482
2001 Perreten V, Schwarz FV, Teuber M, Levy SB. Mdt(A), a new efflux protein conferring multiple antibiotic resistance in Lactococcus lactis and Escherichia coli. Antimicrobial Agents and Chemotherapy. 45: 1109-14. PMID 11257023 DOI: 10.1128/Aac.45.4.1109-1114.2001  0.433
2001 Casaz P, Happel A, Keithan J, Read DL, Strain SR, Levy SB. The Pseudomonas fluorescens transcription activator AdnA is required for adhesion and motility. Microbiology (Reading, England). 147: 355-61. PMID 11158352 DOI: 10.1099/00221287-147-2-355  0.331
2001 Koutsolioutsou A, Martins EA, White DG, Levy SB, Demple B. A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (Serovar typhimurium). Antimicrobial Agents and Chemotherapy. 45: 38-43. PMID 11120941 DOI: 10.1128/Aac.45.1.38-43.2001  0.483
2000 Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 3: 303-311. PMID 11498398 DOI: 10.1054/Drup.2000.0167  0.485
2000 Levy SB. The future of antibiotics: facing antibiotic resistance. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 6: 101-6. PMID 11449641 DOI: 10.1111/J.1469-0691.2000.Tb02059.X  0.44
2000 Saraceni-Richards CA, Levy SB. Second-site suppressor mutations of inactivating substitutions at gly247 of the tetracycline efflux protein, Tet(B). Journal of Bacteriology. 182: 6514-6. PMID 11053399 DOI: 10.1128/Jb.182.22.6514-6516.2000  0.376
2000 Levy SB. Antibiotic and antiseptic resistance: impact on public health. The Pediatric Infectious Disease Journal. 19: S120-2. PMID 11052402 DOI: 10.1097/00006454-200010001-00008  0.454
2000 Wong RS, McMurry LM, Levy SB. 'Intergenic' blr gene in Escherichia coli encodes a 41-residue membrane protein affecting intrinsic susceptibility to certain inhibitors of peptidoglycan synthesis. Molecular Microbiology. 37: 364-70. PMID 10931331 DOI: 10.1046/J.1365-2958.2000.01998.X  0.387
2000 Barbosa TM, Levy SB. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. Journal of Bacteriology. 182: 3467-74. PMID 10852879 DOI: 10.1128/Jb.182.12.3467-3474.2000  0.361
2000 Alekshun MN, Kim YS, Levy SB. Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding. Molecular Microbiology. 35: 1394-404. PMID 10760140 DOI: 10.1046/J.1365-2958.2000.01802.X  0.337
2000 Kern WV, Oethinger M, Jellen-Ritter AS, Levy SB. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy. 44: 814-20. PMID 10722475 DOI: 10.1128/Aac.44.4.814-820.2000  0.404
2000 Saraceni-Richards CA, Levy SB. Evidence for interactions between helices 5 and 8 and a role for the interdomain loop in tetracycline resistance mediated by hybrid Tet proteins. The Journal of Biological Chemistry. 275: 6101-6. PMID 10692399 DOI: 10.1074/Jbc.275.9.6101  0.389
2000 Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrobial Agents and Chemotherapy. 44: 10-3. PMID 10602715 DOI: 10.1128/Aac.44.1.10-13.2000  0.455
1999 Alekshun MN, Levy SB. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends in Microbiology. 7: 410-3. PMID 10498949 DOI: 10.1016/S0966-842X(99)01589-9  0.442
1999 Alekshun MN, Levy SB. Alteration of the repressor activity of MarR, the negative regulator of the Escherichia coli marRAB locus, by multiple chemicals in vitro. Journal of Bacteriology. 181: 4669-72. PMID 10419969 DOI: 10.1128/Jb.181.15.4669-4672.1999  0.422
1999 Nelson ML, Levy SB. Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein. Antimicrobial Agents and Chemotherapy. 43: 1719-24. PMID 10390229 DOI: 10.1128/Aac.43.7.1719  0.45
1999 Levy SB, McMurry LM, Barbosa TM, Burdett V, Courvalin P, Hillen W, Roberts MC, Rood JI, Taylor DE. Nomenclature for new tetracycline resistance determinants. Antimicrobial Agents and Chemotherapy. 43: 1523-4. PMID 10348788 DOI: 10.1128/Aac.43.6.1523  0.426
1999 Alekshun MN, Levy SB. Characterization of MarR superrepressor mutants. Journal of Bacteriology. 181: 3303-6. PMID 10322039 DOI: 10.1128/Jb.181.10.3303-3306.1999  0.407
1999 McMurry LM, McDermott PF, Levy SB. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrobial Agents and Chemotherapy. 43: 711-3. PMID 10049298 DOI: 10.1128/Aac.43.3.711  0.458
1998 Levy SB, Nelson M. Reversing tetracycline resistance. A renaissance for the tetracycline family of antibiotics. Advances in Experimental Medicine and Biology. 456: 17-25. PMID 10549362  0.311
1998 McMurry LM, Oethinger M, Levy SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. Fems Microbiology Letters. 166: 305-9. PMID 9770288 DOI: 10.1111/J.1574-6968.1998.Tb13905.X  0.444
1998 Levy SB. Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment. Bmj (Clinical Research Ed.). 317: 612-3. PMID 9727983 DOI: 10.1136/Bmj.317.7159.612  0.486
1998 McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature. 394: 531-2. PMID 9707111 DOI: 10.1038/28970  0.309
1998 Oethinger M, Podglajen I, Kern WV, Levy SB. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrobial Agents and Chemotherapy. 42: 2089-94. PMID 9687412 DOI: 10.1128/Aac.42.8.2089  0.451
1998 McDermott PF, White DG, Podglajen I, Alekshun MN, Levy SB. Multidrug resistance following expression of the Escherichia coli marA gene in Mycobacterium smegmatis. Journal of Bacteriology. 180: 2995-8. PMID 9603894 DOI: 10.1128/Jb.180.11.2995-2998.1998  0.514
1998 Levy SB. Multidrug resistance--a sign of the times. The New England Journal of Medicine. 338: 1376-8. PMID 9571260 DOI: 10.1056/Nejm199805073381909  0.462
1998 Oethinger M, Kern WV, Goldman JD, Levy SB. Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli. The Journal of Antimicrobial Chemotherapy. 41: 111-4. PMID 9511045 DOI: 10.1093/Jac/41.1.111  0.468
1998 Levy SB. The challenge of antibiotic resistance. Scientific American. 278: 46-53. PMID 9487702 DOI: 10.1038/Scientificamerican0398-46  0.465
1998 Levy SB. Fighting The Specter Of Antibiotic Resistance Infectious Diseases in Clinical Practice. 7: 261-264. DOI: 10.1097/00019048-199808000-00006  0.471
1998 Levy SB, Nelson M. Reversing Tetracycline Resistance Advances in Experimental Medicine and Biology. 456: 17-25. DOI: 10.1007/978-1-4615-4897-3_3  0.46
1997 Moken MC, McMurry LM, Levy SB. Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrobial Agents and Chemotherapy. 41: 2770-2. PMID 9420057 DOI: 10.1128/Aac.41.12.2770  0.408
1997 White DG, Maneewannakul K, von Hofe E, Zillman M, Eisenberg W, Field AK, Levy SB. Inhibition of the multiple antibiotic resistance (mar) operon in Escherichia coli by antisense DNA analogs. Antimicrobial Agents and Chemotherapy. 41: 2699-704. PMID 9420041 DOI: 10.1128/Aac.41.12.2699  0.477
1997 Modrak DE, Draper MP, Levy SB. Emergence of different mechanisms of resistance in the evolution of multidrug resistance in murine erythroleukemia cell lines. Biochemical Pharmacology. 54: 1297-306. PMID 9393672 DOI: 10.1016/S0006-2952(97)00346-8  0.431
1997 Kennan RM, McMurry LM, Levy SB, Rood JI. Glutamate residues located within putative transmembrane helices are essential for TetA(P)-mediated tetracycline efflux. Journal of Bacteriology. 179: 7011-5. PMID 9371447 DOI: 10.1128/Jb.179.22.7011-7015.1997  0.327
1997 Alekshun MN, Levy SB. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrobial Agents and Chemotherapy. 41: 2067-75. PMID 9333027 DOI: 10.1128/Aac.41.10.2067  0.52
1997 White DG, Goldman JD, Demple B, Levy SB. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. Journal of Bacteriology. 179: 6122-6. PMID 9324261 DOI: 10.1128/Jb.179.19.6122-6126.1997  0.376
1997 Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 25: 584-99. PMID 9314444 DOI: 10.1086/513766  0.445
1997 Levy SB. Antibiotic resistance: an ecological imbalance. Ciba Foundation Symposium. 207: 1-9; discussion 9-14. PMID 9189631  0.367
1997 Draper MP, Martell RL, Levy SB. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. British Journal of Cancer. 75: 810-5. PMID 9062400 DOI: 10.1038/Bjc.1997.145  0.376
1997 Draper MP, Martell RL, Levy SB. Active efflux of the free acid form of the fluorescent dye 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein in multidrug-resistance-protein-overexpressing murine and human leukemia cells. European Journal of Biochemistry / Febs. 243: 219-24. PMID 9030742 DOI: 10.1111/J.1432-1033.1997.0219A.X  0.391
1997 Martell RL, Slapak CA, Levy SB. Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3. British Journal of Cancer. 75: 161-8. PMID 9010020 DOI: 10.1038/Bjc.1997.27  0.341
1997 Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infection Control and Hospital Epidemiology. 18: 275-291. DOI: 10.2307/30141215  0.445
1996 Slapak CA, Martell RL, Terashima M, Levy SB. Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP). Biochemical Pharmacology. 52: 1569-76. PMID 8937472 DOI: 10.1016/S0006-2952(96)00561-8  0.305
1996 Levy SB. Antibiotic resistance worldwide--a Spanish task force responds. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 23: 824-6. PMID 8909853 DOI: 10.1093/Clinids/23.4.824  0.37
1996 Bhushan A, Slapak CA, Levy SB, Tritton TR. Expression of c-fos precedes MDR3 in vincristine and adriamycin selected multidrug resistant murine erythroleukemia cells. Biochemical and Biophysical Research Communications. 226: 819-21. PMID 8831695 DOI: 10.1006/Bbrc.1996.1434  0.406
1996 Aldema ML, McMurry LM, Walmsley AR, Levy SB. Purification of the Tn10-specified tetracycline efflux antiporter TetA in a native state as a polyhistidine fusion protein. Molecular Microbiology. 19: 187-95. PMID 8821947 DOI: 10.1046/J.1365-2958.1996.359886.X  0.351
1996 Maneewannakul K, Levy SB. Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrobial Agents and Chemotherapy. 40: 1695-8. PMID 8807064 DOI: 10.1128/Aac.40.7.1695  0.488
1996 Goldman JD, White DG, Levy SB. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrobial Agents and Chemotherapy. 40: 1266-9. PMID 8723480 DOI: 10.1128/Aac.40.5.1266  0.506
1996 Hächler H, Cohen SP, Levy SB. Untranslated sequence upstream of MarA in the multiple antibiotic resistance locus of Escherichia coli is related to the effector-binding domain of the XylS transcriptional activator. Journal of Molecular Evolution. 42: 409-13. PMID 8642609 DOI: 10.1007/Bf02498634  0.35
1995 Levy SB. Antimicrobial resistance: a global perspective. Advances in Experimental Medicine and Biology. 390: 1-13. PMID 8718598 DOI: 10.1007/978-1-4757-9203-4_1  0.356
1995 Seoane AS, Levy SB. Identification of new genes regulated by the marRAB operon in Escherichia coli. Journal of Bacteriology. 177: 530-5. PMID 7836283 DOI: 10.1128/Jb.177.3.530-535.1995  0.404
1995 Seoane AS, Levy SB. Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli. Journal of Bacteriology. 177: 3414-9. PMID 7768850 DOI: 10.1128/Jb.177.12.3414-3419.1995  0.416
1994 Deflaun MF, Marshall BM, Kulle EP, Levy SB. Tn5 Insertion Mutants of Pseudomonas fluorescens Defective in Adhesion to Soil and Seeds. Applied and Environmental Microbiology. 60: 2637-42. PMID 16349340 DOI: 10.1128/Aem.60.7.2637-2642.1994  0.314
1994 Ariza RR, Cohen SP, Bachhawat N, Levy SB, Demple B. Repressor mutations in the marRAB operon that activate oxidative stress genes and multiple antibiotic resistance in Escherichia coli. Journal of Bacteriology. 176: 143-8. PMID 8282690 DOI: 10.1128/Jb.176.1.143-148.1994  0.433
1994 McMurry LM, George AM, Levy SB. Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple-antibiotic-resistant (Mar) mutants. Antimicrobial Agents and Chemotherapy. 38: 542-6. PMID 8203852 DOI: 10.1128/Aac.38.3.542  0.503
1994 Nelson ML, Park BH, Levy SB. Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria. Journal of Medicinal Chemistry. 37: 1355-61. PMID 8176712 DOI: 10.1021/Jm00035A016  0.41
1994 Sloan J, McMurry LM, Lyras D, Levy SB, Rood JI. The Clostridium perfringens Tet P determinant comprises two overlapping genes: tetA(P), which mediates active tetracycline efflux, and tetB(P), which is related to the ribosomal protection family of tetracycline-resistance determinants. Molecular Microbiology. 11: 403-15. PMID 8170402 DOI: 10.1111/J.1365-2958.1994.Tb00320.X  0.387
1994 Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf JM, Levy SB. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Cancer Research. 54: 5607-13. PMID 7923205  0.313
1994 Levy SB. Balancing the drug-resistance equation. Trends in Microbiology. 2: 341-2. PMID 7850197 DOI: 10.1016/0966-842X(94)90607-6  0.333
1993 Levy SB. Confronting multidrug resistance. A role for each of us. Jama. 269: 1840-2. PMID 8459518  0.331
1993 Nelson ML, Park BH, Andrews JS, Georgian VA, Thomas RC, Levy SB. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines. Journal of Medicinal Chemistry. 36: 370-7. PMID 8426364 DOI: 10.1021/Jm00055A008  0.382
1993 Cohen SP, Hächler H, Levy SB. Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli. Journal of Bacteriology. 175: 1484-92. PMID 8383113 DOI: 10.1128/Jb.175.5.1484-1492.1993  0.429
1993 Cohen SP, Yan W, Levy SB. A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. The Journal of Infectious Diseases. 168: 484-8. PMID 8335992 DOI: 10.1093/Infdis/168.2.484  0.488
1993 Summers AO, Wireman J, Vimy MJ, Lorscheider FL, Marshall B, Levy SB, Bennett S, Billard L. Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrobial Agents and Chemotherapy. 37: 825-34. PMID 8280208 DOI: 10.1128/Aac.37.4.825  0.476
1993 Hansen LM, McMurry LM, Levy SB, Hirsh DC. A new tetracycline resistance determinant, Tet H, from Pasteurella multocida specifying active efflux of tetracycline. Antimicrobial Agents and Chemotherapy. 37: 2699-705. PMID 8109938 DOI: 10.1128/Aac.37.12.2699  0.459
1993 Levy SB. Detecting multidrug resistant tuberculosis early. Lancet. 341: 664-5. PMID 8095575 DOI: 10.1016/0140-6736(93)90426-H  0.366
1993 Cohen SP, Levy SB, Foulds J, Rosner JL. Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. Journal of Bacteriology. 175: 7856-62. PMID 7504664 DOI: 10.1128/Jb.175.24.7856-7862.1993  0.471
1993 Levy SB. Confronting Multidrug Resistance: A Role for Each of Us Jama. 269: 1840-1842. DOI: 10.1001/Jama.1993.03500140092042  0.457
1992 Levy SB. Active efflux mechanisms for antimicrobial resistance. Antimicrobial Agents and Chemotherapy. 36: 695-703. PMID 1503431 DOI: 10.1128/Aac.36.4.695  0.442
1992 Seoane A, Sabbaj A, McMurry LM, Levy SB. Multiple antibiotic susceptibility associated with inactivation of the prc gene. Journal of Bacteriology. 174: 7844-7. PMID 1447154 DOI: 10.1128/Jb.174.23.7844-7847.1992  0.399
1992 McMurry LM, Stephan M, Levy SB. Decreased function of the class B tetracycline efflux protein Tet with mutations at aspartate 15, a putative intramembrane residue. Journal of Bacteriology. 174: 6294-7. PMID 1328154 DOI: 10.1128/Jb.174.19.6294-6297.1992  0.423
1991 Rubin RA, Levy SB. Tet protein domains interact productively to mediate tetracycline resistance when present on separate polypeptides. Journal of Bacteriology. 173: 4503-9. PMID 2066343 DOI: 10.1128/Jb.173.14.4503-4509.1991  0.327
1991 Levy SB. Antibiotic availability and use: consequences to man and his environment. Journal of Clinical Epidemiology. 44: 83S-87S. PMID 2045847 DOI: 10.1016/0895-4356(91)90117-R  0.427
1991 Hächler H, Cohen SP, Levy SB. marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli. Journal of Bacteriology. 173: 5532-8. PMID 1715857 DOI: 10.1128/Jb.173.17.5532-5538.1991  0.448
1990 Deflaun MF, Tanzer AS, McAteer AL, Marshall B, Levy SB. Development of an Adhesion Assay and Characterization of an Adhesion-Deficient Mutant of Pseudomonas fluorescens. Applied and Environmental Microbiology. 56: 112-9. PMID 16348082 DOI: 10.1128/Aem.56.1.112-119.1990  0.315
1990 Rubin RA, Levy SB, Heinrikson RL, Kézdy FJ. Gene duplication in the evolution of the two complementing domains of gram-negative bacterial tetracycline efflux proteins. Gene. 87: 7-13. PMID 2332166 DOI: 10.1016/0378-1119(90)90489-E  0.365
1990 Marshall B, Petrowski D, Levy SB. Inter- and intraspecies spread of Escherichia coli in a farm environment in the absence of antibiotic usage. Proceedings of the National Academy of Sciences of the United States of America. 87: 6609-13. PMID 2204058 DOI: 10.1073/Pnas.87.17.6609  0.4
1990 Levy SB. Starting life resistance-free. The New England Journal of Medicine. 323: 335-7. PMID 2195348 DOI: 10.1056/Nejm199008023230509  0.468
1990 Rubin RA, Levy SB. Interdomain hybrid Tet proteins confer tetracycline resistance only when they are derived from closely related members of the tet gene family. Journal of Bacteriology. 172: 2303-12. PMID 2185211 DOI: 10.1128/Jb.172.5.2303-2312.1990  0.302
1990 Hickman RK, McMurry LM, Levy SB. Overproduction and purification of the Tn10-specified inner membrane tetracycline resistance protein Tet using fusions to beta-galactosidase. Molecular Microbiology. 4: 1241-51. PMID 2177817 DOI: 10.1111/J.1365-2958.1990.Tb00703.X  0.387
1990 Slapak CA, Daniel JC, Levy SB. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression. Cancer Research. 50: 7895-901. PMID 1979251  0.354
1989 Levy SB, McMurry LM, Burdett V, Courvalin P, Hillen W, Roberts MC, Taylor DE. Nomenclature for tetracycline resistance determinants. Antimicrobial Agents and Chemotherapy. 33: 1373-4. PMID 2802561 DOI: 10.1128/Aac.33.8.1373  0.394
1989 Cohen SP, McMurry LM, Hooper DC, Wolfson JS, Levy SB. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrobial Agents and Chemotherapy. 33: 1318-25. PMID 2679373 DOI: 10.1128/Aac.33.8.1318  0.479
1989 Levy SB. Evolution and spread of tetracycline resistance determinants. The Journal of Antimicrobial Chemotherapy. 24: 1-3. PMID 2674098 DOI: 10.1093/Jac/24.1.1  0.449
1988 Hickman RK, Levy SB. Evidence that TET protein functions as a multimer in the inner membrane of Escherichia coli. Journal of Bacteriology. 170: 1715-20. PMID 3280550 DOI: 10.1128/Jb.170.4.1715-1720.1988  0.395
1988 Levy SB, Marshall B, Schluederberg S, Rowse D, Davis J. High frequency of antimicrobial resistance in human fecal flora. Antimicrobial Agents and Chemotherapy. 32: 1801-6. PMID 3266729 DOI: 10.1128/Aac.32.12.1801  0.456
1988 Compeau G, Al-Achi BJ, Platsouka E, Levy SB. Survival of rifampin-resistant mutants of Pseudomonas fluorescens and Pseudomonas putida in soil systems. Applied and Environmental Microbiology. 54: 2432-8. PMID 3144244 DOI: 10.1128/Aem.54.10.2432-2438.1988  0.337
1988 De Togni P, Fox HB, Morrissey S, Tansey LR, Levy SB, Babior BM. Plasmids in bacteria exposed to activated neutrophils mediate mutagenesis when transferred to new hosts. Blood. 71: 463-6. PMID 3122860 DOI: 10.1182/Blood.V71.2.463.463  0.348
1988 Park BH, Levy SB. The cryptic tetracycline resistance determinant on Tn4400 mediates tetracycline degradation as well as tetracycline efflux. Antimicrobial Agents and Chemotherapy. 32: 1797-800. PMID 3072922 DOI: 10.1128/Aac.32.12.1797  0.489
1988 Cohen SP, Hooper DC, Wolfson JS, Souza KS, McMurry LM, Levy SB. Endogenous active efflux of norfloxacin in susceptible Escherichia coli. Antimicrobial Agents and Chemotherapy. 32: 1187-91. PMID 3056253 DOI: 10.1128/Aac.32.8.1187  0.357
1988 DePaola A, Flynn PA, McPhearson RM, Levy SB. Phenotypic and genotypic characterization of tetracycline- and oxytetracycline-resistant Aeromonas hydrophila from cultured channel catfish (Ictalurus punctatus) and their environments. Applied and Environmental Microbiology. 54: 1861-3. PMID 3046493 DOI: 10.1128/Aem.54.7.1861-1863.1988  0.407
1988 Cohen SP, McMurry LM, Levy SB. marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. Journal of Bacteriology. 170: 5416-22. PMID 2848006 DOI: 10.1128/Jb.170.12.5416-5422.1988  0.402
1987 Levy SB. Antibiotic Use for Growth Promotion in Animals: Ecologic and Public Health Consequences. Journal of Food Protection. 50: 616-620. PMID 30965484 DOI: 10.4315/0362-028X-50.7.616  0.465
1987 Park BH, Hendricks M, Malamy MH, Tally FP, Levy SB. Cryptic tetracycline resistance determinant (class F) from Bacteroides fragilis mediates resistance in Escherichia coli by actively reducing tetracycline accumulation. Antimicrobial Agents and Chemotherapy. 31: 1739-43. PMID 3324960 DOI: 10.1128/Aac.31.11.1739  0.48
1987 McMurry LM, Park BH, Burdett V, Levy SB. Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci. Antimicrobial Agents and Chemotherapy. 31: 1648-50. PMID 3324958 DOI: 10.1128/Aac.31.10.1648  0.449
1987 Fox HB, De Togni P, McMahon G, Levy SB, Robinson JS, Karnovsky MJ, Babior BM. Fate of the DNA in plasmid-containing Escherichia coli minicells ingested by human neutrophils. Blood. 69: 1394-400. PMID 3032306 DOI: 10.1182/Blood.V69.5.1394.1394  0.373
1987 Heuer C, Hickman RK, Curiale MS, Hillen W, Levy SB. Constitutive expression of tetracycline resistance mediated by a Tn10-like element in Haemophilus parainfluenzae results from a mutation in the repressor gene. Journal of Bacteriology. 169: 990-4. PMID 3029042 DOI: 10.1128/Jb.169.3.990-994.1987  0.461
1987 McMurry LM, Levy SB. Tn5 insertion in the polynucleotide phosphorylase (pnp) gene in Escherichia coli increases susceptibility to antibiotics. Journal of Bacteriology. 169: 1321-4. PMID 3029034 DOI: 10.1128/Jb.169.3.1321-1324.1987  0.38
1986 Rashtchian A, Brown SW, Reichler J, Levy SB. Plasmid segregation into minicells is associated with membrane attachment and independent of plasmid replication. Journal of Bacteriology. 165: 82-7. PMID 3510193 DOI: 10.1128/Jb.165.1.82-87.1986  0.31
1986 Marshall B, Morrissey S, Flynn P, Levy SB. A new tetracycline-resistance determinant, class E, isolated from Enterobacteriaceae. Gene. 50: 111-7. PMID 3034728 DOI: 10.1016/0378-1119(86)90315-X  0.473
1986 McMurry LM, Hendricks M, Levy SB. Effects of toluene permeabilization and cell deenergization on tetracycline resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy. 29: 681-6. PMID 3010853 DOI: 10.1128/Aac.29.4.681  0.484
1986 Bradley DE, Taylor DE, Levy SB, Cohen DR, Brose EC, Whelan J. pIN32: a cointegrate plasmid with IncHI2 and IncFII components. Journal of General Microbiology. 132: 1339-46. PMID 2877047 DOI: 10.1099/00221287-132-5-1339  0.315
1985 Rolland RM, Hausfater G, Marshall B, Levy SB. Antibiotic-resistant bacteria in wild primates: increased prevalence in baboons feeding on human refuse. Applied and Environmental Microbiology. 49: 791-4. PMID 4004213 DOI: 10.1128/Aem.49.4.791-794.1985  0.469
1985 Levy SB. Man, animals and antibiotic resistance. Pediatric Infectious Disease. 4: 3-5. PMID 3969364 DOI: 10.1097/00006454-198501000-00002  0.456
1985 Levy SB. Antibiotics in animals. Nature. 313: 344. PMID 3969143 DOI: 10.1038/313344A0  0.34
1985 Levy SB, Hedges RW, Sullivan F, Medeiros AA, Sosroseputro H. Multiple antibiotic resistance plasmids in Enterobacteriaceae isolated from diarrhoeal specimens of hospitalized children in Indonesia. The Journal of Antimicrobial Chemotherapy. 16: 7-16. PMID 3876328 DOI: 10.1093/Jac/16.1.7  0.457
1984 Marshall B, Roberts M, Smith A, Levy SB. Homogeneity of transferable tetracycline-resistance determinants in Haemophilus species. The Journal of Infectious Diseases. 149: 1028-9. PMID 6330236 DOI: 10.1093/Infdis/149.6.1028  0.373
1984 Curiale MS, McMurry LM, Levy SB. Intracistronic complementation of the tetracycline resistance membrane protein of Tn10. Journal of Bacteriology. 157: 211-7. PMID 6317652 DOI: 10.1128/Jb.157.1.211-217.1984  0.433
1984 Levy SB, Buu-Hoi A, Marshall B. Transposon Tn10-like tetracycline resistance determinants in Haemophilus parainfluenzae. Journal of Bacteriology. 160: 87-94. PMID 6090437 DOI: 10.1128/Jb.160.1.87-94.1984  0.438
1984 Levy SB. l'Évolution des résistances bactèriennes. Surveillance locale et mondiale* Medecine Et Maladies Infectieuses. 14: 779-787. DOI: 10.1016/S0399-077X(84)80164-X  0.31
1984 Levy SB. Antibiotics in the environment: Threat vs benefit Antimicrobic Newsletter. 1: 11-14. DOI: 10.1016/0738-1751(84)90019-4  0.341
1983 Marshall B, Tachibana C, Levy SB. Frequency of tetracycline resistance determinant classes among lactose-fermenting coliforms. Antimicrobial Agents and Chemotherapy. 24: 835-40. PMID 6660856 DOI: 10.1128/Aac.24.6.835  0.336
1983 Woytowicz JM, Daoust PR, André-Schwartz J, Levy SB. Expression of multiple isozymes of granulocyte, monocyte, and macrophage esterases in polycythemic Friend erythroleukemia cells. Blood. 62: 425-32. PMID 6575839 DOI: 10.1182/Blood.V62.2.425.Bloodjournal622425  0.305
1983 McMurry LM, Aronson DA, Levy SB. Susceptible Escherichia coli cells can actively excrete tetracyclines. Antimicrobial Agents and Chemotherapy. 24: 544-51. PMID 6418064 DOI: 10.1128/Aac.24.4.544  0.376
1983 George AM, Levy SB. Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. Journal of Bacteriology. 155: 531-40. PMID 6348022 DOI: 10.1128/Jb.155.2.531-540.1983  0.5
1983 Levy SB. Antibiotic resistance. Infection Control : Ic. 4: 195-7. PMID 6309691  0.369
1983 George AM, Levy SB. Gene in the major cotransduction gap of the Escherichia coli K-12 linkage map required for the expression of chromosomal resistance to tetracycline and other antibiotics. Journal of Bacteriology. 155: 541-8. PMID 6307967 DOI: 10.1128/Jb.155.2.541-548.1983  0.478
1982 McMurry LM, Cullinane JC, Levy SB. Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains. Antimicrobial Agents and Chemotherapy. 22: 791-9. PMID 6758689 DOI: 10.1128/Aac.22.5.791  0.479
1982 Curiale MS, Levy SB. Two complementation groups mediate tetracycline resistance determined by Tn10. Journal of Bacteriology. 151: 209-15. PMID 6282805 DOI: 10.1128/Jb.151.1.209-215.1982  0.446
1982 Levy SB. Microbial resistance to antibiotics. An evolving and persistent problem. Lancet. 2: 83-8. PMID 6123819 DOI: 10.1016/S0140-6736(82)91701-9  0.433
1981 McMurry LM, Cullinane JC, Petrucci RE, Levy SB. Active uptake of tetracycline by membrane vesicles from susceptible Escherichia coli. Antimicrobial Agents and Chemotherapy. 20: 307-13. PMID 7030198 DOI: 10.1128/Aac.20.3.307  0.308
1981 Marshall B, Schluederberg S, Tachibana C, Levy SB. Survival and transfer in the human gut of poorly mobilizable (pBR322) and of transferable plasmids from the same carrier E. coli. Gene. 14: 145-54. PMID 7026365 DOI: 10.1016/0378-1119(81)90110-4  0.31
1981 Onderdonk A, Marshall B, Cisneros R, Levy SB. Competition between congenic Escherichia coli K-12 strains in vivo. Infection and Immunity. 32: 74-9. PMID 7012037 DOI: 10.1128/Iai.32.1.74-79.1981  0.432
1980 McMurry L, Petrucci RE, Levy SB. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 77: 3974-7. PMID 7001450 DOI: 10.1073/Pnas.77.7.3974  0.437
1980 Ferrazza D, Levy SB. Biochemical and immunological characterization of an R plasmid-encoded protein with properties resembling those of major cellular outer membrane proteins. Journal of Bacteriology. 144: 149-58. PMID 6998944 DOI: 10.1128/Jb.144.1.149-158.1980  0.333
1980 Marshall B, Levy SB. Prevalence of amber suppressor-containing coliforms in the natural environment. Nature. 286: 524-5. PMID 6995858 DOI: 10.1038/286524A0  0.324
1980 Levy SB, Marshall B, Rowse-Eagle D, Onderdonk A. Survival of Escherichia coli host-vector systems in the mammalian intestine. Science (New York, N.Y.). 209: 391-4. PMID 6992276 DOI: 10.1126/Science.6992276  0.311
1980 Mendez B, Tachibana C, Levy SB. Heterogeneity of tetracycline resistance determinants. Plasmid. 3: 99-108. PMID 6927764 DOI: 10.1016/0147-619X(80)90101-8  0.417
1978 Levy SB, McMurry L. Plasmid-determined tetracycline resistance involves new transport systems for tetracycline. Nature. 276: 90-2. PMID 368642 DOI: 10.1038/276090A0  0.506
1978 Levy SB, Sullivan N, Gorbach SL. Pathogenicity of conventional and debilitated Escherichia coli K12. Nature. 274: 395-6. PMID 353562 DOI: 10.1038/274395A0  0.335
1978 Levy SB. Emergence of antibiotic-resistant bacteria in the intestinal flora of farm inhabitants. The Journal of Infectious Diseases. 137: 689-90. PMID 351088 DOI: 10.1093/Infdis/137.5.688  0.479
1976 Levy SB, Rubenstein CB, Friend C. The spleen in Friend leukemia. I. Prolonged survival of leukemic mice after autoimplantation of spleen tissue. Journal of the National Cancer Institute. 56: 1183-8. PMID 1069138 DOI: 10.1093/Jnci/56.6.1183  0.473
1976 Levy SB, FitzGerald GB, Macone AB. Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. The New England Journal of Medicine. 295: 583-8. PMID 950974 DOI: 10.1056/Nejm197609092951103  0.45
1976 Yang HL, Zubay G, Levy SB. Synthesis of an R plasmid protein associated with tetracycline resistance is negatively regulated. Proceedings of the National Academy of Sciences of the United States of America. 73: 1509-12. PMID 775491 DOI: 10.1073/Pnas.73.5.1509  0.388
1976 Levy SB, FitzGerald GB, Macone AB. Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man. Nature. 260: 40-2. PMID 772441 DOI: 10.1038/260040A0  0.416
1974 Levy SB. Use of mucoid bacterial mutants to circumvent clumping of cells and minicells containing R plasmids derepressed for pilus synthesis. Journal of Bacteriology. 120: 534-5. PMID 4608737 DOI: 10.1128/Jb.120.1.534-535.1974  0.32
1974 Levy SB, McMurry L. Detection of an inducible membrane protein associated with R-factor-mediated tetracycline resistance. Biochemical and Biophysical Research Communications. 56: 1060-8. PMID 4596957 DOI: 10.1016/S0006-291X(74)80296-2  0.387
1970 Levy SB. Resistance of minicells to penicillin lysis: a method of obtaining large quantities of purified minicells. Journal of Bacteriology. 103: 836-839. PMID 4919994 DOI: 10.1128/Jb.103.3.836-839.1970  0.416
1970 Levy SB, Norman P. Segregation of Transferable R Factors into Escherichia coli Minicells Nature. 227: 606-607. PMID 4913916 DOI: 10.1038/227606A0  0.321
Show low-probability matches.